Live Breaking News & Updates on 022 Prnewswire Sequential Skin Ltd

LONDON and NEW YORK and SINGAPORE, June 29, 2022 /PRNewswire/ Sequential Skin Ltd, a leading skin genomics start-up, has been awarded an Innovate UK SMART Grant to fund a project on advancing current understanding of the skin microbiome in healthy and diseased skin - using their novel testing kits. Atopic dermatitis (AD) is a multifactorial chronic and recurrent inflammatory skin disease, affecting 20% of children and 10% of adults. Roughly 29% are moderate to severe cases, with healthcare and socio-economic costs of Pound 723M per year. This US $500k (equivalent to Pound 400k) project will be funded over 18 months to further the understanding of genetic and skin microbiome inputs, during disease progression, that may lead to helping to identify and stratify patients in the future. "We see a future where patients with recurrent and debilitating skin conditions are diagnosed in a highly precise way, at the point of care, which can then be followed by effective and targeted treatme ....

United Kingdom , City Of , Ben Holmes , Natalya Fox , Oliver Worsley , Sequential Skin Ltd , Innovate United Kingdom , Dermatology Registrar , Albert Dashi , Scrum Ventures , London And New York Singapore , June 29 , 022 Prnewswire Sequential Skin Ltd , A Leading Skin Genomics Start Up , As Been Awarded An Innovate Uk Smart Grant To Funda Project On Advancing Current Understanding Of The Skin Microbiome In Healthy And Diseased Using Their Novel Testing Kits Atopic Dermatitis Ad Isa Multifactorial Chronic Recurrent Inflammatory Disease , Ffecting 20 Of Children And 10 Adults Roughly 29 Are Moderate To Severe Cases , Ith Healthcare And Socio Economic Costs Of Pound 723m Per Year This Us 500k Equivalent To 400k Project Will Be Funded Over 18 Months Further The Understanding Genetic Skin Microbiome Inputs , Uring Disease Progression , Hat May Lead To Helping Identify And Stratify Patients In The Future Quot We Seea Where With Recurrent Debilitating Skin Conditions Are Diagnosed Ina Highly Precise Way , T The Point Of Care , Hich Can Then Be Followed By Effective And Targeted Treatment Quot , Aid Oliver Worsley , Nd Co Founder Highly Disruptive To Skin Health Sequential Willworkalongside Dermatologistsinthe Nhs Recruit Patients And Benefit From Clinicians Experienced In Ad Quot Asa Dermatologist , Equential 39s Technology Will Be Highly Disruptive In Changing The Way Ad Patients Could Diagnosed And Better Treated Futurei 39m Proud To Involved With Sequential Team This Project , Uot Added Dr Natalya Fox , A Dermatology Registrar At St George 39s Hospital Sequential Has Already Commercialised Its Skin Microbiome Testing Kit For The Personal Care Industry Validated With Over 30 ,